PD Dr. Markus Eckstein



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Diagnostic and predictive molecular pathology of urothelial carcinoma: Current status and outlook for the future Diagnostische und prädiktive Molekularpathologie des Urothelkarzinoms: Bestandsaufnahme und Ausblick in die Zukunft (2026) Rauch S, Lange F, Hartmann A, Eckstein M Journal article Assessment of EGFR and HER2 expression in penile cancer as potential therapeutic targets (2026) Mink JN, Boehle J, Eckstein M, Fiegl A, Khalmurzaev O, Pryalukhin A, Geppert CI, et al. Journal article Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy (2025) Rinderknecht E, Claps F, Bostrom PJ, Shariat SF, Neuzillet Y, Zlotta AR, Trombetta C, et al. Journal article Loss of p190A RhoGAP induces aneuploidy and enhances bladder cancer cell migration and invasion by modulating actin dynamics (2025) Kang Q, Kong X, Najjar G, Azoitei A, Eckstein M, John A, Zengerling F, et al. Journal article TROP-2 overexpression in papillary renal cell carcinoma supports its potential as a therapeutic target for antibody-drug-conjugate therapy (2025) Kessler C, von Brandenstein M, Klümper N, Krausewitz P, Storz E, Rieger C, Sperber L, et al. Journal article DLL3 Expression in Neuroendocrine Carcinomas and Neuroendocrine Tumours: Insights From a Multicentric Cohort of 1294 Pulmonary and Extrapulmonary Neuroendocrine Neoplasms (2025) Schmitt M, Bohnenberger H, Bartsch DK, Wagner DC, Litmeyer AS, Grass A, Rinke A, et al. Journal article BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease (2025) Bucci L, Böltz S, Hagen M, Tur C, Nöthling DM, Rothe T, Wirsching A, et al. Journal article Checkpoint Blockade Efficacy in Uveal Melanoma Is Linked to Tumor Immunity, CD28, and CCL8 (2025) Koch E, Liguori R, Castro AA, Schliep S, Petzold A, Wessely A, Fröhlich W, et al. Journal article Expression and therapeutic potential of TROP2 in cisplatin-resistant germ cell tumors (2025) Sperber L, von Brandenstein M, Kessler C, Heidenreich J, Storz E, Pfister D, Paffenholz P, et al. Journal article Das muskelinvasive und metastasierte Urothelkarzinom aus Sicht der Pathologie (2025) Klümper N, Kalogirou C, Eckstein M Journal article